| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators
|
Falagario, Ugo Giovanni
|
|
|
3 |
5 |
p. 700-704
|
article
|
| 2 |
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study
|
Grivas, Petros
|
|
|
3 |
5 |
p. 695-699
|
article
|
| 3 |
Contents
|
|
|
|
3 |
5 |
p. iii-vi
|
article
|
| 4 |
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
|
Srivastava, Tushar
|
|
|
3 |
5 |
p. 663-670
|
article
|
| 5 |
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups
|
Preisser, Felix
|
|
|
3 |
5 |
p. 631-639
|
article
|
| 6 |
Editorial Board
|
|
|
|
3 |
5 |
p. i-ii
|
article
|
| 7 |
How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is Unavailable
|
Witjes, Johannes Alfred
|
|
|
3 |
5 |
p. 705-709
|
article
|
| 8 |
Imaging and T Category for Prostate Cancer in the 8th Edition of the Union for International Cancer Control TNM Classification
|
van der Poel, Henk
|
|
|
3 |
5 |
p. 563-564
|
article
|
| 9 |
Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers
|
Martinez Chanza, Nieves
|
|
|
3 |
5 |
p. 671-679
|
article
|
| 10 |
Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer
|
Olsson, Henrik
|
|
|
3 |
5 |
p. 640-647
|
article
|
| 11 |
Internal and External Validation of a 90-Day Percentage Erection Fullness Score Model Predicting Potency Recovery Following Robot-assisted Radical Prostatectomy
|
Huynh, Linda M.
|
|
|
3 |
5 |
p. 657-662
|
article
|
| 12 |
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review
|
Marra, Giancarlo
|
|
|
3 |
5 |
p. 565-581
|
article
|
| 13 |
PARP Inhibitors in Prostate Cancer: A Promise Delivered
|
Tripathi, Abhishek
|
|
|
3 |
5 |
p. 612-614
|
article
|
| 14 |
PI-QUAL, a New System for Evaluating Prostate Magnetic Resonance Imaging Quality: Is Beauty in the Eye of the Beholder?
|
Turkbey, Baris
|
|
|
3 |
5 |
p. 620-621
|
article
|
| 15 |
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study
|
Knaapila, Juha
|
|
|
3 |
5 |
p. 648-656
|
article
|
| 16 |
Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors
|
Alessandrino, Francesco
|
|
|
3 |
5 |
p. 680-686
|
article
|
| 17 |
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial
|
Giganti, Francesco
|
|
|
3 |
5 |
p. 615-619
|
article
|
| 18 |
Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 2020;296:76–84
|
Jambor, Ivan
|
|
|
3 |
5 |
p. 714-715
|
article
|
| 19 |
Re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study. Eur Urol Oncol 2020;3:648–656
|
Jue, Joshua S.
|
|
|
3 |
5 |
p. 710
|
article
|
| 20 |
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16
|
Evangelista, Laura
|
|
|
3 |
5 |
p. 713
|
article
|
| 21 |
Reply to Joshua S. Jue and Mahmoud Alameddine’s Letter to the Editor re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study. Eur Urol Oncol 2020;3:648–656
|
Knaapila, Juha
|
|
|
3 |
5 |
p. 711-712
|
article
|
| 22 |
Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment
|
Koti, Madhuri
|
|
|
3 |
5 |
p. 622-630
|
article
|
| 23 |
Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials
|
Connor, Martin J.
|
|
|
3 |
5 |
p. 582-593
|
article
|
| 24 |
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial
|
Tannir, Nizar M.
|
|
|
3 |
5 |
p. 687-694
|
article
|
| 25 |
When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials
|
Antonarakis, Emmanuel S.
|
|
|
3 |
5 |
p. 594-611
|
article
|
Journal description